CARY – Biopharma AstraZeneca has picked SAS to help search for new drug candidates utilizing SAS’ data analytics suite and artificial intelligence as part of what a SAS exec called a “transformation program.” The deal was announced Tuesday. Financial terms weren’t disclosed. “This partnership with SAS supports the transformation...
Read More
AstraZeneca has booked its first profit from sales of its COVID-19 vaccine. Here’s the latest.
Read More
AstraZeneca’s vaccine is key to ending the global economic slump caused by the coronavirus. But a series of missteps by the drugmaker and new concerns over blood clots risk undermining public confidence in the shot and delaying the recovery.
Read More
After teaming up with Oxford University, AstraZeneca produced a safe and effective COVID-19 vaccine in just nine months, a huge achievement that will help end the pandemic. But a series of missteps along the way has led to scathing criticism from policymakers and health officials.
Read More
The United Kingdom on Wednesday become the first country to approve the coronavirus vaccine developed by Oxford University and AstraZeneca. The shot is cheaper and easier to distribute than alternatives, and is expected to play a crucial role in boosting the global economy next year.
Read More
Half a million US children have been diagnosed with Covid-19, according to the American Academy of Pediatrics and the Children’s Hospital Association. The news came on the same day that AstraZeneca said it weas pausing its test of a potential vaccine.
Read More
AstraZeneca has approached rival drugmaker Gilead about a potential merger, according to a Bloomberg report. Here’s the latest.
Read More
DURHAM –British drug company AstraZeneca has slapped a patent suit on Durham-based generic drug seller Accord Healthcare. The suit, filed in New Jersey federal court, alleges Accord infringed on its patents for a breast cancer drug. The suit says Accord filed an abbreviated new drug application with the U.S....
Read More
